PTGS2 and colorectal adenoma: Clinical trials with nonsteroidal anti-inflammatory drugs (NSAIDs) and aspirin, inhibitors of cyclooxygenase-2 (COX-2), have demonstrated success in the prevention of colorectal adenomas via reduction in PGE2 [4].